A. Saiga

发表

cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence

K. Nakahara, M. Osame, R. Kubota, 1997, Journal of virology.

Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia Cells*

K. Kawamoto, Katsutoshi Yamada, H. Arita, 1999, The Journal of Biological Chemistry.

A spontaneous point mutation in the human T-cell leukemia virus type 1 pX gene leads to expression of a novel doubly spliced pX-mRNA that encodes a 25-kD, amino-terminal deleted rex protein.

M. Osame, R. Kubota, H. Igarashi, 1994, DNA and cell biology.

Human T cell leukaemia virus type 1 p21X mRNA: constitutive expression in peripheral blood mononuclear cells of patients with adult T cell leukaemia.

K. Araki, H. Igarashi, A. Saiga, 1992, The Journal of general virology.

Synthesis and in vivo behavior of a copper‐64‐labeled dithiosemicarbazone derivative coupled to a dihydropyridine carrier

Y. Magata, H. Saji, A. Yokoyama, 1993 .

Potent Modification of Low Density Lipoprotein by Group X Secretory Phospholipase A2 Is Linked to Macrophage Foam Cell Formation*

Katsutoshi Yamada, Shigenori Yamamoto, H. Arita, 2002, The Journal of Biological Chemistry.

Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution.

Y. Magata, H. Saji, A. Yoshitake, 1992, Chemical & pharmaceutical bulletin.

Presence of antibodies to p21X and/or p27rex proteins in sera from human T-cell leukemia virus type I-infected individuals.

H. Igarashi, A. Saiga, S. Orita, 1996, Journal of virological methods.

Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.

N. Fujii, H. Arita, K. Hanasaki, 2000, Archives of biochemistry and biophysics.

Human T-cell leukemia virus type 1 protease protein expressed inEscherichia coli possesses aspartic proteinase activity

S. Sato, T. Fujiwara, K. Abe, 2005, Archives of Virology.

Differences between group X and group V secretory phospholipase A2 in lipolytic modification of lipoproteins

Katsutoshi Yamada, Shigenori Yamamoto, S. Kamitani, 2012, Cellular & Molecular Biology Letters.

Potential role of group X secretory phospholipase A2 in cyclooxygenase‐2‐dependent PGE2 formation during colon tumorigenesis

H. Arita, K. Hanasaki, A. Saiga, 2000, FEBS letters.

Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 alpha.

Takao Shimizu, N. Uozumi, H. Arita, 2005, Prostaglandins & other lipid mediators.

Group X secretory phospholipase A(2) induces potent productions of various lipid mediators in mouse peritoneal macrophages.

H. Arita, K. Hanasaki, A. Saiga, 2001, Biochimica et biophysica acta.

Evaluation of Production and Characterization of Monoclonal Antibodies to Human IgG of Four Subclasses

S. Hosoi, S. Harada, A. Saiga, 1989, Microbiology and immunology.

A novel alternatively spliced viral mRNA transcribed in cells infected with human T cell leukemia virus type 1 is mainly responsible for expressing p21X protein

H. Igarashi, A. Saiga, S. Orita, 1991, FEBS letters.

Differences between group X and group V secretory phospholipase A2 in lipolytic modification of lipoproteins

Katsutoshi Yamada, Shigenori Yamamoto, S. Kamitani, 2012, Cellular & Molecular Biology Letters.